Mylan Inc (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar HayZeus (41.53) Submitted: 9/18/2013 5:20:41 PM : Outperform Start Price: $38.59 MYL Score: +3.67

GENERICS FOR EVERYONE

Featured Broker Partners


Advertisement